School of Medicine, Department of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Arthritis Res Ther. 2023 Feb 9;25(1):20. doi: 10.1186/s13075-023-02999-8.
Previous studies have shown systemic lupus erythematosus (SLE) patients had a significantly higher prevalence of thyroid diseases and hypothyroidism than matched controls, and some case reports showed SLE may occur after Hashimoto's thyroiditis (HT).
This study aimed to investigate the subsequent risk of SLE in patients with HT.
In this retrospective cohort study done by the Taiwan National Health Insurance Research Database, the HT group (exposure group) and the non-HT group (comparator group) were propensity score matched at a ratio of 1:2 by demographic data, comorbidities, medications, and the index date. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Several sensitivity analyses were done for cross-validation of our findings.
We identified 15,512 HT patients and matched 31,024 individuals. The incidence rate ratio of SLE was 3.58 (95% CI, 2.43-5.28; p < 0.01). Several sensitivity analyses show adjusted hazard ratio (aHR) (CIs) of 4.35 (3.28-5.76), 4.39 (3.31-5.82), 5.11 (3.75-6.98), and 4.70 (3.46-6.38), consistent with the results of the main model.
Our study showed an increased risk of SLE in the HT group after adjustment for baseline characteristics, comorbidities, and medical confounders compared with the reference group.
先前的研究表明,系统性红斑狼疮(SLE)患者患甲状腺疾病和甲状腺功能减退症的患病率明显高于匹配对照者,一些病例报告显示,SLE 可能发生在桥本甲状腺炎(HT)之后。
本研究旨在探讨 HT 患者发生 SLE 的后续风险。
本回顾性队列研究采用台湾全民健康保险研究数据库进行,通过人口统计学数据、合并症、药物和索引日期,将 HT 组(暴露组)和非-HT 组(对照组)以 1:2 的比例进行倾向评分匹配。我们使用 Cox 比例风险模型来估计风险比(HR)和 95%置信区间(CI)。进行了几项敏感性分析以交叉验证我们的发现。
我们确定了 15512 例 HT 患者,并匹配了 31024 名个体。SLE 的发病率比值为 3.58(95%CI,2.43-5.28;p<0.01)。几项敏感性分析显示,调整后的危险比(aHR)(CI)为 4.35(3.28-5.76)、4.39(3.31-5.82)、5.11(3.75-6.98)和 4.70(3.46-6.38),与主要模型的结果一致。
与对照组相比,我们的研究表明,在调整了基线特征、合并症和医疗混杂因素后,HT 组发生 SLE 的风险增加。